A critical appraisal of Interferon-based Adjuvant Therapy in stage II-III malignant melanoma

Lex Eggermont

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)563-569
Number of pages7
JournalExpert Rev. Anticancer Ther.
Volume2
Issue number5
Publication statusPublished - 2002

Cite this